Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)

ASX: FPH Statistics

Total Valuation

Fisher & Paykel Healthcare Corporation has a market cap or net worth of AUD 20.11 billion. The enterprise value is 20.14 billion.

Market Cap	20.11B
Enterprise Value	20.14B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.85%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	583.80M

Valuation Ratios

The trailing PE ratio is 122.75.

PE Ratio	122.75
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	11.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.18, with an EV/FCF ratio of 53.06.

EV / Earnings	122.94
EV / Sales	11.79
EV / EBITDA	41.18
EV / EBIT	53.18
EV / FCF	53.06

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.08.

Current Ratio	2.06
Quick Ratio	1.03
Debt / Equity	0.08
Debt / EBITDA	0.28
Debt / FCF	0.36
Interest Coverage	29.09

Financial Efficiency

Return on equity (ROE) is 9.70% and return on invested capital (ROIC) is 12.60%.

Return on Equity (ROE)	9.70%
Return on Assets (ROA)	10.85%
Return on Capital (ROIC)	12.60%
Revenue Per Employee	247,696
Profits Per Employee	23,390
Employee Count	7,031
Asset Turnover	0.78
Inventory Turnover	2.15

Taxes

In the past 12 months, Fisher & Paykel Healthcare Corporation has paid 92.78 million in taxes.

Income Tax	92.78M
Effective Tax Rate	43.74%

Stock Price Statistics

The stock price has increased by +53.21% in the last 52 weeks. The beta is 0.42, so Fisher & Paykel Healthcare Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+53.21%
50-Day Moving Average	33.85
200-Day Moving Average	30.29
Relative Strength Index (RSI)	51.73
Average Volume (20 Days)	448,202

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fisher & Paykel Healthcare Corporation had revenue of AUD 1.74 billion and earned 163.85 million in profits. Earnings per share was 0.28.

Revenue	1.74B
Gross Profit	1.05B
Operating Income	384.51M
Pretax Income	276.75M
Net Income	163.85M
EBITDA	479.24M
EBIT	384.51M
Earnings Per Share (EPS)	0.28

Balance Sheet

The company has 107.03 million in cash and 138.51 million in debt, giving a net cash position of -31.48 million.

Cash & Cash Equivalents	107.03M
Total Debt	138.51M
Net Cash	-31.48M
Net Cash Per Share	n/a
Equity (Book Value)	1.77B
Book Value Per Share	3.02
Working Capital	362.57M

Cash Flow

In the last 12 months, operating cash flow was 464.55 million and capital expenditures -84.91 million, giving a free cash flow of 379.64 million.

Operating Cash Flow	464.55M
Capital Expenditures	-84.91M
Free Cash Flow	379.64M
FCF Per Share	n/a

Margins

Gross margin is 60.68%, with operating and profit margins of 22.16% and 9.44%.

Gross Margin	60.68%
Operating Margin	22.16%
Pretax Margin	15.95%
Profit Margin	9.44%
EBITDA Margin	27.62%
EBIT Margin	22.16%
FCF Margin	21.88%

Dividends & Yields

Fisher & Paykel Healthcare Corporation does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	1.44%
Years of Dividend Growth	11
Payout Ratio	69.51%
Buyback Yield	-0.85%
Shareholder Yield	-0.85%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on September 27, 2004. It was a forward split with a ratio of 5.

Last Split Date	Sep 27, 2004
Split Type	Forward
Split Ratio	5

Scores

Fisher & Paykel Healthcare Corporation has an Altman Z-Score of 21.13 and a Piotroski F-Score of 3.

Altman Z-Score	21.13
Piotroski F-Score	3